XM tidak memberikan layanan kepada penduduk Amerika Serikat.

UK insurer Phoenix halts SunLife sale on regulatory uncertainty



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-UK insurer Phoenix halts SunLife sale on regulatory uncertainty</title></head><body>

Britain's financial watchdog examining pure protection insurance

Shares fell 2.8% as SunLife news overshadowed strong results

Phoenix's H1 cash generation and profit surpassed expectations

Adds CEO comments in paragraphs 3,5, background and shares throughout

By Yadarisa Shabong

Sept 16 (Reuters) -British insurer Phoenix Group PHNX.L has stopped the sale process of its SunLife business, it said on Monday, citing regulatory scrutiny into what is known as the pure protection insurance market, sending its shares lower.

Phoenix's pure protection products are designed to help policyholders manage their finances if they become unable to meet financial commitments. It distributes them through the SunLife brand, which earns commission.

Britain's financial watchdog in August launched a market study into sales of pure protection insurance products following concern the design of some commission structures could lead to poor outcomes for policyholders.

"The uncertainty around commission was a concern for potential purchasers," CEO Andy Briggs told Reuters.

A sale of the SunLife brand would have split the manufacturing and the distribution of the products, Briggs said, raising concerns about lower commissions to SunLife.

Shares fell 2.8% in early trade as the SunLife news overshadowed Phoenix's first-half earnings and total cash that surpassed market expectations on pensions and savings business growth.

Phoenix reported total cash generation of 950 million pounds ($1.25 billion) in the six months to June 30, surpassing expectations of about 739 million pounds in a company-compiled consensus.

The company, which specialises in buying up and managing books of life insurance business closed to new customers, said it was confident of delivering total cash at the top end of its previous target range of 1.4 billion to 1.5 billion pounds in 2024.

The insurer's half-yearly adjusted operating profit increased 15% to 360 million pounds, though analysts had forecast an earnings of about 348 million pounds.

Phoenix, which has been expanding into the bulk annuities market, said written annuity premiums were 1.7 billion pounds in the first half, down nearly 47% on last year.

Still, Briggs said he was positive for bulk annuity deals and that new players were starting to enter the market.

Bulk annuities, which have slowed this year after hitting record levels last year, are a form of insurance whereby a company's pension plan offloads liabilities to an insurer.

($1 = 0.7603 pounds)



Reporting by Yadarisa Shabong in Bengaluru; Editing by Sherry Jacob-Phillips and Barbara Lewis

</body></html>

Pengungkapan: Entitas XM Group menyediakan layanan khusus eksekusi dan akses ke Fasilitas Trading Online kami, yang memungkinkan Anda untuk melihat dan/atau menggunakan konten yang tersedia pada atau melalui situs, yang tidak untuk mengubah atau memperluas, serta tidak mengubah atau memperluas hal tersebut. Akses dan penggunaan ini selalu sesuai dengan: (i) Syarat dan Ketentuan; (ii) Peringatan Risiko; dan (iii) Pengungkapan Penuh. Oleh karena itu, konten disediakan hanya sebagai informasi umum. Anda juga harus ketahui bahwa konten Fasilitas Trading Online kami bukan sebagai ajakan atau tawaran untuk untuk melakukan transaksi apa pun di pasar finansial. Trading di pasar finansial mana pun melibatkan tingkat risiko yang signifikan pada modal Anda.

Semua materi yang diterbitkan di Fasilitas Trading Online kami hanya untuk tujuan edukasi/informasi dan tidak boleh mengandung nasihat dan rekomendasi finansial, pajak investasi atau trading, catatan harga trading kami, penawaran, permintaan, transaksi dalam instrumen finansial apa pun atau promo finansial untuk Anda yang tidak diminta.

Konten pihak ketiga apa pun, serta konten yang disiapkan oleh XM, seperti opini, berita, riset, analisis, harga, informasi lain atau link ke situs pihak ketiga yang tersedia "sebagaimana adanya", sebagai komentar pasar umum dan bukan menjadi nasihat investasi. Sejauh konten apa pun ditafsirkan sebagai penelitian investasi, Anda harus memperhatikan dan menerima bahwa konten tersebut tidak dimaksudkan dan belum disiapkan sesuai dengan persyaratan hukum yang dirancang untuk mempromosikan kemandirian riset investasi dan dengan demikian akan dianggap sebagai komunikasi pemasaran di bawah hukum dan peraturan yang relevan. Mohon dipastikan bahwa Anda telah membaca dan memahami Notifikasi pada Riset Investasi Non-Independen dan Peringatan Risiko kami mengenai informasi di atas, yang dapat diakses disini.

Peringatan Resiko: Modal Anda beresiko. Produk dengan leverage mungkin tidak cocok bagi semua orang. Silahkan pertimbangkan Pengungkapan Resiko kami.